We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+9.56%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$731M
AUM Growth
-$60.4M
Cap. Flow
-$453M
Cap. Flow %
-62.05%
Top 10 Hldgs %
62.84%
Holding
133
New
81
Increased
1
Reduced
15
Closed
33
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACKIU
51
DELISTED
Ackrell SPAC Partners I Co Units
ACKIU
$2.58M 0.35%
+250,374
New +$2.55M
ALTUU
52
DELISTED
Altitude Acquisition Corp Unit
ALTUU
$2.49M 0.34%
+240,859
New +$2.48M
HZON.U
53
DELISTED
Horizon Acquisition Corporation II Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
HZON.U
$2.46M 0.34%
+228,954
New +$2.36M
KSMT
54
DELISTED
Kismet Acquisition One Corp Ordinary Shares
KSMT
$2.24M 0.31%
+222,022
New +$2.18M
PIAI
55
DELISTED
Prime Impact Acquisition I
PIAI
$2.23M 0.31%
+221,233
New +$2.19M
PMVC
56
DELISTED
PMV Consumer Acquisition Corp.
PMVC
$2.22M 0.3%
+219,138
New +$2.16M
HUMA icon
57
Humacyte
HUMA
$168M
$2.17M 0.3%
+213,750
New +$2.12M
OTRAU
58
DELISTED
OTR Acquisition Corp. Unit
OTRAU
$2.15M 0.29%
+204,933
New +$2.09M
RNAC icon
59
Cartesian Therapeutics
RNAC
$218M
$2.14M 0.29%
23,522
-169,364
-88% -$14.7M
PIAI.U
60
DELISTED
Prime Impact Acquisition I Units, each consisting of one Class A ordinary share, and one-third of a redeemable Warrant to acquire one Class A ordinary share
PIAI.U
$2.1M 0.29%
+198,000
New +$2.01M
BURU
61
DELISTED
NUBURU INC
BURU
$2.02M 0.28%
+974
New +$1.92M
IIAC.U
62
DELISTED
Investindustrial Acquisition Corp. Units, each consisting of one Class A ordinary share and one-thir
IIAC.U
$2M 0.27%
+194,979
New +$2M
GNK icon
63
Genco Shipping & Trading
GNK
$1.1B
$1.97M 0.27%
267,145
-1,035,013
-79% -$7.53M
SRRA
64
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$1.75M 0.24%
108,914
-304,895
-74% -$4.23M
ACIC
65
DELISTED
Atlas Crest Investment Corp.
ACIC
$1.74M 0.24%
+172,731
New +$1.75M
AVAN
66
DELISTED
Avanti Acquisition Corp.
AVAN
$1.73M 0.24%
+168,578
New +$1.68M
OWLT icon
67
Owlet
OWLT
$147M
$1.72M 0.24%
+12,098
New +$1.67M
ADOC
68
DELISTED
Edoc Acquisition Corp. Class A Ordinary Share
ADOC
$1.71M 0.23%
+166,898
New +$1.68M
NMMCU
69
DELISTED
North Mountain Merger Corp. Unit
NMMCU
$1.56M 0.21%
+145,705
New +$1.51M
CAI
70
DELISTED
CAI International, Inc.
CAI
$1.55M 0.21%
49,529
-795,983
-94% -$24.2M
NGACU
71
DELISTED
NextGen Acquisition Corporation Units
NGACU
$1.4M 0.19%
+136,364
New +$1.37M
SGAMU
72
DELISTED
Seaport Global Acquisition Corp. Unit
SGAMU
$1.36M 0.19%
+130,451
New +$1.35M
LIVK
73
DELISTED
LIV Capital Acquisition Corp. Class A Ordinary Shares
LIVK
$1.32M 0.18%
+130,700
New +$1.3M
BWAC
74
DELISTED
BETTER WORLD ACQUISITION CORP. Common Stock
BWAC
$1.27M 0.17%
+124,800
New +$1.27M
XOS icon
75
Xos
XOS
$26.8M
$1.21M 0.17%
+4,003
New +$1.2M

Similar funds

Mangrove Partners's Q4 2020 Portfolio in Review

As of Q4 2020, Mangrove Partners held 133 positions worth $731M, down 7.6% from $791M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Mangrove Partners withdrew a net $453M in Q4 2020, closing 33 positions and reducing 15 holdings. Its most notable exit was PG&E, an estimated $43.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 7.8% of assets, down from 9.2% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Mangrove Partners opened a new position in ScION Tech Growth I Unit worth $11.5M.

  • Mangrove Partners's largest Q4 2020 buy was ScION Tech Growth I Unit: 1,114,998 shares worth $11.5M.
  • Mangrove Partners added most to Bristol-Myers Squibb Company Contingent Value Rights in Q4 2020, an estimated $9.18M increase.
  • Mangrove Partners's biggest Q4 2020 reduction was Civitas Resources, cutting an estimated $35.1M.
  • Mangrove Partners fully exited PG&E in Q4 2020, selling an estimated $43.2M.
  • Mangrove Partners's ten largest holdings make up 63% of its $731M portfolio in Q4 2020.
  • Mangrove Partners opened 81 new positions and closed 33 in Q4 2020.
  • Mangrove Partners's portfolio value fell 7.6% quarter-over-quarter to $731M.

Based on Mangrove Partners's 13F filing for Q4 2020, filed 16 Feb 2021.